The roles of 5‐HT in orofacial pain

• Published in: Oral diseases Vol. 30; no. 6; pp. 3838 - 3849
• Main Authors: Zou, Zhishan, Fan, Wenguo, Liu, Haotian, Liu, Qing, He, Hongwen, Huang, Fang
• Format: Journal Article
• Language: English
• Published: Denmark Wiley Subscription Services, Inc 01.09.2024
• Subjects: 5‐HT; 5‐HT receptors; Animals; Chronic pain; Chronic Pain - drug therapy; Chronic Pain - metabolism; Chronic Pain - physiopathology; Facial Pain - drug therapy; Facial Pain - physiopathology; Humans; Monoamines; Neuromodulation; orofacial pain; Pain; pain modulation; Quality of life; Reviews; Serotonin - metabolism; Serotonin - physiology; orofacial pain; 5‐HT receptors; 5‐HT; pain modulation
• ISSN: 1354-523X; 1601-0825; 1601-0825
• DOI: 10.1111/odi.14960

Objectives Acute and chronic orofacial pain are very common and remain a vexing health problem that has a negative effect on the quality of life. Serotonin (5‐HydroxyTryptamine, 5‐HT) is a kind of monoamine neurotransmitter that is involved in many physiological and pathological processes. However, its role in orofacial pain remains inconclusive. Therefore, this review aims to summarize the recent advances in understanding the effect exerted by 5‐HT on the modulation of orofacial pain. Subjects and Methods An extensive search was conducted on PubMed and Web of Science for pertinent studies focusing on the effects of 5‐HT on the modulation of orofacial pain. Results In this review, we concisely review how 5‐HT mediates orofacial pain, how 5‐HT is regulated and how we can translate these findings into clinical applications for the prevention and/or treatment of orofacial pain. Conclusions 5‐HT plays a key role in the modulation of orofacial pain, implying that 5‐HT modulators may serve as effective treatment for orofacial pain. However, further research on the precise mechanisms underlying the modulation of orofacial pain is still warranted.